MetaCap

Faeth Therapeutics (FTH) vs Yarrow Bioscience (YARW)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Faeth Therapeutics (FTH) has outperformed Yarrow Bioscience (YARW) over the past year, losing 9.6% versus a loss of 26.7%. Over five years, FTH leads with a -95.0% price change compared with -98.6% for YARW. Faeth Therapeutics is the larger company by market cap ($203.7 million vs $196.5 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FTH-9.64%YARW-26.70%
+379%+166%-46%
Nov 21, 20251 yearNov 20, 2026
FTH-95.34%YARW-98.66%
+47%-29%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FTH versus YARW key metrics
MetricFTHYARW
Share price$7.88$12.90
Market cap$203.65M$196.53M
1-day change-9.32%-9.35%
YTD return-26.15%-55.52%
1-year return-9.64%-26.70%
5-year return-94.96%-98.61%
EPS (TTM)$-22.50—
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$570.00K
Revenue growth (YoY)—+13.77%
Net income (latest FY)$-21.09M$-26.48M
Operating margin—-5219.12%
Net margin—-4646.14%
52-week high$42.14$46.95
52-week low$7.45$12.39
Distance from 52-week high-81.30%-72.52%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+612.56%+310.85%
Average volume500.25K153.34K
Shares outstanding25.84M15.23M
Employees297
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FTH has outperformed YARW by 17.1 percentage points over the past year.

About Faeth Therapeutics

FTH stock →

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees

About Yarrow Bioscience

YARW stock →

Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees

FTH vs YARW FAQ

Which is bigger, Faeth Therapeutics or Yarrow Bioscience?

Faeth Therapeutics (FTH) is larger, with a market capitalization of $203.65M compared with $196.53M for Yarrow Bioscience (YARW).

Which stock has performed better over the past year, FTH or YARW?

FTH returned -9.64% over the past 12 months, compared with -26.70% for YARW (price return, excluding dividends). Past performance does not predict future results.

Are Faeth Therapeutics and Yarrow Bioscience in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons